(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PUREMIDINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PUREMIDINE

ST13

US500000090871461

Class

1

Filing

90871461

Registration

7300088

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

02/06/2024

Trademark type

Word

Nice classes

1

Filing date

08/08/2021

Registration date

02/06/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/06/2024

Last transaction

02/06/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/01/2019

First use in commerce

12/01/2019

Drawing code

4

Owner type

99

Owner location

Nanjing, CN

Examiner

ROCCA, ALAINA

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Nanjing Nutrabuilding Bio-tech Co., Ltd.

Representatives

Xingyi Tao

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Spermidine and mixtures containing Spermidine all used as raw ingredients for the manufacture of foods and nutritional and dietary supplements; derivatives of Spermidine being saltspolymersestersacidsmixtures containing derivatives of Spermidineall used as raw ingredients for the manufacture of foods and nutritional and dietary supplements; Spermidine isomers and mixtures containing Spermidine isomers all used as raw ingredients for the manufacture of foods and nutritional and dietary supplements; derivatives of Spermidine isomers being saltspolymersestersacidsmixtures containing derivatives of Spermidine isomersall used as raw ingredients for the manufacture of foods and nutritional and dietary supplements

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/06/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/03/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/02/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/02/2023

ALIE

ASSIGNED TO LIE

11/02/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/01/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/07/2023

GNRT

NON-FINAL ACTION E-MAILED

04/07/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/07/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/07/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/06/2023

IUAF

USE AMENDMENT FILED

02/17/2023

EISU

TEAS STATEMENT OF USE RECEIVED

02/17/2023

DOCK

ASSIGNED TO EXAMINER

01/12/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/30/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/05/2022

PUBO

PUBLISHED FOR OPPOSITION

07/05/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/15/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/01/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

05/13/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/13/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

05/13/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/13/2022

DOCK

ASSIGNED TO EXAMINER

05/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2021

NWAP

NEW APPLICATION ENTERED

08/11/2021

Continuous trademark protection

Get notified about every new filing that threatens PUREMIDINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.